FDA Okays Breo Ellipta for Asthma in Adults
The once-daily treatment combines the inhaled corticosteroid fluticasone furoate and the long-acting beta2-agonist vilanterol. FDA Approvals …read more
The once-daily treatment combines the inhaled corticosteroid fluticasone furoate and the long-acting beta2-agonist vilanterol. FDA Approvals …read more
Women at average risk are screened too early, too often, and too late in life, according to newly released best-practice advice. Medscape Medical News …read more
The agency urges clinicians to keep using the antiseptic products in question for the sake of infection control, even as it looks at the possible effects of daily, long-term use. News Alerts …read more
The percentage of infants born with neonatal abstinence syndrome (NAS) was nearly twice as high in 2012 as it was 2011, report Dr. S. W. Patrick and coauthors from the department of pediatrics at… …read more
A new study finds that women diagnosed with luminal A breast cancer have a 30% reduced risk of the cancer returning if they have a history of breastfeeding. …read more
A new study suggests that negative life events and lifetime traumatic events could increase the risk of heart attack among middle-aged and older women. …read more
Study finds tumor type may also influence outcomesWomen diagnosed with breast cancer who previously breastfed their babies had a 30 percent overall decreased risk of the disease recurring… …read more
National survey: Women are largely unaware of many symptoms and risks of strokesA national survey released by The Ohio State University Wexner Medical Center shows that most women don’t know the… …read more